Terns Pharmaceuticals (TERN)
(Delayed Data from NSDQ)
$7.53 USD
-0.65 (-7.95%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $7.68 +0.15 (1.99%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TERN 7.53 -0.65(-7.95%)
Will TERN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TERN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TERN
Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)
TERN: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy
Other News for TERN
TERN forms Jack-in-the-box Bullish on September 19
Is TERN set to rally? Expansion Breakout shows up after rocketing 10.54%
Mizuho Securities Sticks to Their Buy Rating for Terns Pharmaceuticals (TERN)
Roche deal to buy 89bio boosts MASH space
Is TERN compressing before expansion? Bollinger Band Squeeze shows up after rising 1.37%